# Amides from Porcelia ponderosa Roots Display Efficacy In Vitro Against Intracellular Amastigotes of Trypanosoma cruzi

**Authors:** Carlos Henrique T. Dos Santos, Mariana B. Abiuzi, Beatriz A. De Andrade, Erica V. C. Levatti, Mariana H. Chaves, Andre G. Tempone, João Henrique G. Lago

PMC · DOI: 10.1002/cbdv.202503258 · 2026-02-26

## TL;DR

Amides isolated from Porcelia ponderosa roots show strong activity against Trypanosoma cruzi parasites in lab tests.

## Contribution

This is the first experimental evidence of amides from P. ponderosa showing efficacy against T. cruzi intracellular amastigotes.

## Key findings

- Compounds 1 and 2 showed potent activity with EC50 values of 6.3 ± 1.2 and 3.4 ± 0.6 µM, respectively.
- Compound 3 showed moderate activity with an EC50 of 14.0 ± 0.3 µM.
- Simplified derivatives of the amides were inactive, highlighting the importance of their specific chemical structure.

## Abstract

In the present work, the MeOH extract from roots of Porcelia ponderosa R.E. Fries (Annonaceae) was subjected to several chromatographic techniques to afford three chemically related amides: N‐trans‐p‐coumaroyltyramine (1), N‐trans‐caffeoyltyramine (2), and N‐trans‐feruloyltyramine (3). Isolated compounds were characterized by NMR and MS spectral analysis. This is the first report of compounds 1–3 in P. ponderosa, while 1 is a previously unreported metabolite from the Porcelia genus. Previous studies reported the effects of amides 1–3 on the inhibition of sterol 14‐α‐demethylase (CYP51), a key enzyme in the life cycle of Trypanosoma cruzi, using an in silico approach. However, no experimental evidence was conducted to prove their effects against the parasite. Based on these data and isolation of amides 1–3 from roots of P. ponderosa, these compounds were tested in vitro against the intracellular amastigotes of T. cruzi. Compounds 1 and 2, containing p‐coumaroyl and caffeic moieties, displayed potent activity with EC50 values of 6.3 ± 1.2 and 3.4 ± 0.6 µM, respectively, a similar efficacy observed to the standard drug benznidazole (EC50 of 5.5 ± 2.2 µM). Otherwise, compound 3, with a feruloyl moiety, showed moderate activity (EC50 of 14.0 ± 0.3 µM). These results indicated that p‐coumaric and caffeoyl moieties play an important role in the potency against amastigotes of T. cruzi. Otherwise, simplified derivatives of 1–3 such as p‐coumaric, caffeic and ferulic acids as well as tyramine, showed to be inactive against amastigotes (EC50 > 150 µM) reinforcing the importance of condensation of these free acids and tyramine for the efficacy of amides 1–3. Considering the cytotoxicity against murine fibroblasts, compounds 1–3 displayed CC50 values higher than 200 µM, and SI values higher than 31.7, 55.6, and 14.3, respectively. These findings highlight a safe profile and the antiparasitic potential of amides 1 and 2, which could be used as promising hit compounds for the design of new drug candidates for Chagas disease.

Amides from Porcelia ponderosa display potent activity against amastigotes from Trypanosoma cruzi.

## Linked entities

- **Proteins:** CYP51A1 (cytochrome P450 family 51 subfamily A member 1)
- **Chemicals:** N-trans-p-coumaroyltyramine (PubChem CID 5372945), N-trans-caffeoyltyramine (PubChem CID 9994897), N-trans-feruloyltyramine (PubChem CID 5280537), p-coumaric acid (PubChem CID 637542), caffeic acid (PubChem CID 689043), ferulic acid (PubChem CID 445858), tyramine (PubChem CID 5610), benznidazole (PubChem CID 31593)
- **Diseases:** Chagas disease (MONDO:0001444)
- **Species:** Trypanosoma cruzi (taxon 5693), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), disease (MESH:D004194), NTDs (MESH:D058069), hypotensive (MESH:D007022), deaths (MESH:D003643), infection (MESH:D007239), Cytotoxicity (MESH:D064420), CD (MESH:D014355)
- **Chemicals:** N-trans-caffeoyltyramine (MESH:C481438), silica gel (MESH:D058428), formic acid (MESH:C030544), acetogenins (MESH:D054378), acids (MESH:D000143), CH2Cl2 (MESH:D008752), carboxylic acids (MESH:D002264), paprazine (MESH:C487400), gamma-lactones (MESH:C430364), H2O (MESH:D014867), Amides (MESH:D000577), terpenoids (MESH:D013729), HCl (MESH:D006851), alkaloids (MESH:D000470), SDS (MESH:D012967), nifurtimox (MESH:D009547), 1H (-), tyramine (MESH:D014439), hexane (MESH:D006586), MTT (MESH:C070243), fatty acids (MESH:D005227), CO2 (MESH:D002245), benznidazole (MESH:C009999), CHCl3 (MESH:D002725), H (MESH:D006859), flavonoids (MESH:D005419)
- **Species:** Leishmania infantum (species) [taxon 5671], Mus musculus (house mouse, species) [taxon 10090], Schistosoma mansoni (species) [taxon 6183], Trypanosoma cruzi (species) [taxon 5693], Homo sapiens (human, species) [taxon 9606], Porcelia (genus) [taxon 306974]
- **Cell lines:** NCTC L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0462), /c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103), CVCL_0462 — Homo sapiens (Human), Transformed cell line (CVCL_9A21), NCTC — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_K271)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944134/full.md

---
Source: https://tomesphere.com/paper/PMC12944134